The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The United States sports medicine market size reached US$ 2,411.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 3,139.7 Million by 2027, exhibiting a growth rate (CAGR) of 4.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Sports medicine is a branch of medical science that deals with the diagnosis and treatment of sports and exercise-related injuries. It aids in the treatment of various sports-related injuries, such as strains, sprains, fractures, tendonitis, exercise-relates asthma, heat illness and cartilage and disc injuries. Sports medicine involves numerous treatments, such as osteopathic manipulation, rehabilitation and injections, and products, including body reconstruction products, body support and recovery products and accessories. It emphasizes on providing comprehensive medical care to improve athletic performance and ensuring faster recovery from injuries.
The increasing participation in sports activities and athletics represents one of the key factors favoring the market growth in the United States. This has resulted in the rising instances of sports-related injuries, which, in turn, has contributed to the growing demand for appropriate treatment procedures and products. In line with this, rising awareness regarding physical fitness among the masses has led to the incorporation of sports as a crucial component of their daily regime, thereby enhancing the demand for various sports medicine products. Furthermore, technological advancements, such as the development of Protection, Rest, Ice, Compression and Elevation (PRICE) therapy as the immediate treatment of sports injuries, are acting as other growth-inducing factors. Product manufacturers are also developing 3D printed implants that are highly cost-effective and more durable.
IMARC Group provides an analysis of the key trends in each sub-segment of the United States sports medicine market report, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Northeast, Midwest, South, West|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at